Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3934729 | European Urology Supplements | 2007 | 6 Pages |
Abstract
Conventional LHRH agonists do not induce profound and sustained testosterone suppression in all patients, similar to orchidectomy. To give patients maximum benefit from medical castration via LHRH agonist treatment, we must have new formulations.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Bertrand Tombal,